p.110 抽出テキスト

meta-analysis. J Cardiovasc Nurs 2024;39:390–400. https://doi.org/10. 1097/JCN.0000000000001010 1025. Meng Y, Zhuge W, Huang H, Zhang T, Ge X. The effects of early exercise on cardiac rehabilitation-related outcome in acute heart failure patients: a systematic review and meta-analysis. Int J Nurs Stud 2022;130:104237. https://doi.org/10.1016/j.ijnurstu.2022.104237 1026. Nakaya Y, Akamatsu M, Ogimoto A, Kitaoka H. Early cardiac rehabilitation for acute decompensated heart failure safely improves physical function (PEARL study): a randomized controlled trial. Eur J Phys Rehabil Med 2021;57:985–93. https://doi.org/10.23736/S1973-9087.21.06727-7 1027. Clemente MRC, Felix N, Navalha DDP, Pasqualotto E, Morgado Ferreira RO, Braga MAP, et al. Long-term impact of home-based monitoring after an admission for acute decompensated heart failure: a systematic review and meta-analysis of randomised controlled trials. EClinicalMedicine 2024; 71:102541. https://doi.org/10.1016/j.eclinm.2024.102541 1028. Masotta V, Dante A, Caponnetto V, Marcotullio A, Ferraiuolo F, Bertocchi L, et al. Telehealth care and remote monitoring strategies in heart failure patients: a systematic review and meta-analysis. Heart Lung 2024;64: 149–67. https://doi.org/10.1016/j.hrtlng.2024.01.003 1029. Scholte NTB, Gurgoze MT, Aydin D, Theuns D, Manintveld OC, Ronner E, et al. Telemonitoring for heart failure: a meta-analysis. Eur Heart J 2023; 44:2911–26. https://doi.org/10.1093/eurheartj/ehad280 1030. Caiani EG, Kemps H, Hoogendoorn P, Asteggiano R, Bohm A, Borregaard B, et al. Standardized assessment of evidence supporting the adoption of mobile health solutions: a clinical consensus statement of the ESC Regulatory Affairs Committee: developed in collaboration with the European Heart Rhythm Association (EHRA), the Association of Cardiovascular Nursing & Allied Professions (ACNAP) of the ESC, the Heart Failure Association (HFA) of the ESC, the ESC Young Community, the ESC Working Group on e-Cardiology, the ESC Council for Cardiology Practice, the ESC Council of Cardio-Oncology, the ESC Council on Hypertension, the ESC Patient Forum, the ESC Digital Health Committee, and the European Association of Preventive Cardiology (EAPC). Eur Heart J Digit Health 2024;5:509–23. https://doi.org/10.1093/ehjdh/ztae042 1031. Frederix I, Caiani EG, Dendale P, Anker S, Bax J, Bohm A, et al. ESC e-Cardiology Working Group position paper: overcoming challenges in digital health implementation in cardiovascular medicine. Eur J Prev Cardiol 2019;26:1166–77. https://doi.org/10.1177/2047487319832394 1032. Santobuono VE, Favale S, D’Onofrio A, Manzo M, Calo L, Bertini M, et al. Performance of a multisensor implantable defibrillator algorithm for heart failure monitoring related to co-morbidities. ESC Heart Fail 2023;10: 2469–78. https://doi.org/10.1002/ehf2.14416 1033. Boehmer JP, Hariharan R, Devecchi FG, Smith AL, Molon G, Capucci A, et al. A multisensor algorithm predicts heart failure events in patients with implanted devices: results from the MultiSENSE study. JACC Heart Fail 2017;5:216–25. https://doi.org/10.1016/j.jchf.2016.12.011 1034. Bohm M, Drexler H, Oswald H, Rybak K, Bosch R, Butter C, et al. Fluid status telemedicine alerts for heart failure: a randomized controlled trial. Eur Heart J 2016;37:3154–63. https://doi.org/10.1093/eurheartj/ehw099 1035. van Veldhuisen DJ, Braunschweig F, Conraads V, Ford I, Cowie MR, Jondeau G, et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation 2011;124:1719–26. https://doi.org/10.1161/CIRCULATIONAHA.111.043042 1036. Zito A, Princi G, Romiti GF, Galli M, Basili S, Liuzzo G, et al. Device-based remote monitoring strategies for congestion-guided management of patients with heart failure: a systematic review and meta-analysis. Eur J Heart Fail 2022;24:2333–41. https://doi.org/10.1002/ejhf.2655 1037. Kapelios CJ, Liori S, Bonios M, Abraham WT, Filippatos G. Effect of pulmonary artery pressure-guided management on outcomes of patients with heart failure outside clinical trials: a systematic review and meta-analysis of realworld evidence with the CardioMEMS Heart Failure System. Eur J Heart Fail 2025;27:1857–65. https://doi.org/10.1002/ejhf.3687 1038. de Juan Baguda J, Gavira Gomez JJ, Pachon Iglesias M, Cozar Leon R, Escolar Perez V, Gonzalez Fernandez O, et al. Remote heart failure management using the HeartLogic algorithm. RE-HEART registry. Rev Esp Cardiol (Engl Ed) 2022;75:709–16. https://doi.org/10.1016/j.rec.2021.09.015 1039. Hajduczok AG, Muallem SN, Nudy MS, DeWaters AL, Boehmer JP. Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials. Heart Fail Rev 2022;27:1281–1300. https://doi.org/10.1007/s10741-021- 10150-5 1040. Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 2011;377: 658–66. https://doi.org/10.1016/S0140-6736(11)60101-3 1041. Abraham WT, Stevenson LW, Bourge RC, Lindenfeld JA, Bauman JG, Adamson PB, et al. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. Lancet 2016;387:453–61. https:// doi.org/10.1016/S0140-6736(15)00723-0 1042. Brugts JJ, Radhoe SP, Clephas PRD, Aydin D, van Gent MWF, Szymanski MK, et al. Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial. Lancet 2023;401:2113–23. https://doi.org/10.1016/S0140- 6736(23)00923-6 1043. Clephas PRD, Radhoe SP, Boersma E, Gregson J, Jhund PS, Abraham WT, et al. Efficacy of pulmonary artery pressure monitoring in patients with chronic heart failure: a meta-analysis of three randomized controlled trials. Eur Heart J 2023;44:3658–68. https://doi.org/10.1093/eurheartj/ehad346 1044. Lindenfeld J, Zile MR, Desai AS, Bhatt K, Ducharme A, Horstmanshof D, et al. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial. Lancet 2021;398:991–1001. https://doi.org/ 10.1016/S0140-6736(21)01754-2 1045. Lindenfeld J, Costanzo MR, Zile MR, Ducharme A, Troughton R, Maisel A, et al. Implantable hemodynamic monitors improve survival in patients with heart failure and reduced ejection fraction. J Am Coll Cardiol 2024; 83:682–94. https://doi.org/10.1016/j.jacc.2023.11.030 1046. Guichard JL, Bonno EL, Nassif ME, Khumri TM, Miranda D, Jonsson O, et al. Seated pulmonary artery pressure monitoring in patients with heart failure: results of the PROACTIVE-HF trial. JACC Heart Fail 2024;12:1879–93. https://doi.org/10.1016/j.jchf.2024.05.017 1047. Sharif F, Rosenkranz S, Bartunek J, Kempf T, Assmus B, Mahon NG, et al. Safety and efficacy of a wireless pulmonary artery pressure sensor: primary endpoint results of the SIRONA 2 clinical trial. ESC Heart Fail 2022;9: 2862–72. https://doi.org/10.1002/ehf2.14006 1048. Sharif F, Rosenkranz S, Bartunek J, Kempf T, Assmus B, Mahon NG, et al. Twelve-month follow-up results from the SIRONA 2 clinical trial. ESC Heart Fail 2024;11:1133–43. https://doi.org/10.1002/ehf2.14657 1049. Angermann CE, Assmus B, Anker SD, Asselbergs FW, Brachmann J, Brett ME, et al. Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF). Eur J Heart Fail 2020;22:1891–901. https://doi.org/10.1002/ejhf.1943 1050. Cowie MR, Flett A, Cowburn P, Foley P, Chandrasekaran B, Loke I, et al. Real-world evidence in a national health service: results of the UK CardioMEMS HF system post-market study. ESC Heart Fail 2022;9: 48–56. https://doi.org/10.1002/ehf2.13748 1051. Desai AS, Bhimaraj A, Bharmi R, Jermyn R, Bhatt K, Shavelle D, et al. Ambulatory hemodynamic monitoring reduces heart failure hospitalizations in ‘real-world’ clinical practice. J Am Coll Cardiol 2017;69:2357–65. https:// doi.org/10.1016/j.jacc.2017.03.009 1052. Shavelle DM, Desai AS, Abraham WT, Bourge RC, Raval N, Rathman LD, et al. Lower rates of heart failure and all-cause hospitalizations during pulmonary artery pressure-guided therapy for ambulatory heart failure: oneyear outcomes from the CardioMEMS post-approval study. Circ Heart Fail 2020;13:e006863. https://doi.org/10.1161/CIRCHEARTFAILURE. 119.006863 1053. Inglis SC, Clark RA, Dierckx R, Prieto-Merino D, Cleland JG. Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database Syst Rev 2015;2015:CD007228. https://doi.org/ 10.1002/14651858.CD007228.pub3 1054. Schou M, Gislason G, Videbaek L, Kober L, Tuxen C, Torp-Pedersen C, et al. Effect of extended follow-up in a specialized heart failure clinic on adherence to guideline recommended therapy: NorthStar Adherence Study. Eur J Heart Fail 2014;16:1249–55. https://doi.org/10.1002/ejhf.176 1055. Lund LH, Carrero JJ, Farahmand B, Henriksson KM, Jonsson A, Jernberg T, et al. Association between enrolment in a heart failure quality registry and subsequent mortality: a nationwide cohort study. Eur J Heart Fail 2017; 19:1107–16. https://doi.org/10.1002/ejhf.762 1056. Malgie J, Wilde MI, Brunner-La Rocca HP, Emans ME, De Boer GA, Siegers CEP, et al. Newly diagnosed heart failure with reduced ejection fraction: timing, sequencing, and titration of guideline-recommended medical therapy. Eur Heart J 2025;46:2394–405. https://doi.org/10.1093/eurheartj/ ehaf244 1057. Sauer AJ, Beon C, Cherkur S, Mallas-Serdynski L, Thomas K, Spertus J, et al. Multiregional implementation initiative’s impact on guideline-based performance measures for patients hospitalized with heart failure: IMPLEMENT-HF. Circ Heart Fail 2025;18:e012547. https://doi.org/10. 1161/CIRCHEARTFAILURE.124.012547 1058. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal Downloaded from academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehag100/8766302 by guest on 31 August 2026